Construction of four double gene substitution human x bovine rotavirus reassortant vaccine candidates: Each bears two outer capsid human rotavirus genes, one encoding P serotype 1A and the other encoding G serotype 1,2,3,4 specificity

Journal of Medical Virology

Volumn 51, Issue 4, 1997, Pages 319-325

  Hoshino, Yasutaka ^a   Jones, Ronald W ^a   Chanock, Robert M ^a   Kapikian, Albert Z ^a  

^a NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

Author keywords

Double gene substitution rotavirus reassortants; Rotavirus reassortant vaccines; Rotavirus VP4 and VP7

Indexed keywords

ROTAVIRUS VACCINE;

ANTIGENICITY; ARTICLE; DRUG EFFICACY; DRUG SAFETY; GENETIC RECOMBINATION; HUMAN; NONHUMAN; ROTAVIRUS; VACCINATION;

ANIMALS; ANTIGENS, VIRAL; CAPSID; CAPSID PROTEINS; CATTLE; CELL LINE; CERCOPITHECUS AETHIOPS; GENES, VIRAL; GUINEA PIGS; HUMANS; ROTAVIRUS; VACCINES, SYNTHETIC; VIRAL VACCINES;

EID: 0030973658     PISSN: 01466615     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-9071(199704)51:4<319::AID-JMV10>3.0.CO;2-D     Document Type: Article

References (73)

1. Beards GM, Desselberger U, Flewett TH (1989): Temporal and geographical distributions of human rotavirus serotypes, 1983 to 1988. Journal of Clinical Microbiology 27:2827-2833.
2. Bern C, Unicomb L, Gentsch JR, Banul N, Yunus M, Sack RB, Glass RI (1992): Rotavirus diarrhea in Bangladesh children: Correlation of disease severity with serotypes. Journal of Clinical Microbiology 30:3234-3238.
3. Bern C, Glass RI (1994): Impact of diarrheal diseases worldwide. In Kapikian AZ (ed): "Viral Infections of the Gastrointestinal Tract." New York: Marcel Dekker, pp 1-26.
4. Bernstein DI, Glass RI, Rodgers G, Davidson BL, Sack DA, U.S. Rotavirus Vaccine Efficacy Group (1995): Evaluation of rhesus rotavirus monovalent and tetravalent reassortant vaccines in U.S. children. Journal of American Medical Association 275:1191-1196.
5. Birch CJ, Heath RL, Gust IH (1988): Use of serotype-specific monoclonal antibodies to study epidemiology of rotavirus infection. Journal of Medical Virology 24:45-53.
6. Bishop RF (1993): Development of candidate rotavirus vaccines. Vaccine 11:243-254.
7. Browning GF, Fitzgerald TA, Chalmers RM, Snodgrass DR (1991): A novel group A rotavirus G serotype: serological and genomic characteristics of equine isolate FI23. Journal of Clinical Microbiology 29:2043-2046.
8. Clark HF, Hoshino Y, Bell LM, Groff J, Hess G, Bachman P, Offit PA (1987): Rotavirus WI61 representing a presumptive new human serotype. Journal of Clinical Microbiology 25:1757-1762.
9. Clark HF, Furukawa T, Bell LM, Offit PA, Parrella PA, Plotkin SA (1986a): Immune response of infants and children to low-passage bovine rotavirus (strain WC3). American Journal of Diseases of Children 140:350-356.
10. Clark HF, Offit, PA, Dolan KT, Tezza A, Gogalin K, Twist EM, Plotkin SA (1986b): Response of adult human volunteers to oral administration of bovine and bovine/human reassortant rotaviruses. Vaccine 4:25-31.
11. Conner ME, Matson DO, Estes MK (1994): Rotavirus vaccines and vaccination potential. Current Topics in Microbiology and Immunology 185:286-337.
12. Estes MK (1996): Rotaviruses and their replication. In Fields BN, Knipe DM, Howley PM (eds): "Virology." Philadelphia: Lippincott-Raven, 3rd ed., pp 1625-1655.
13. Estes MK, Cohen J (1989): Rotavirus gene structure and function. Microbiological Reviews 53:410-449.
14. Flores J, Perez-Schael I, Blanco M, Vilar M, Garcia D, Perez M, Daoud N, Midthun K, Kapikian AZ (1989): Reactions to and antigenicity of two human-rhesus rotavirus reassortant vaccine candidates of serotypes 1 and 2 in Venezuelan infants. Journal of Clinical Microbiology 27:512-518.
15. Flores J, Taniguchi K, Green K, Perez-Schael I, Garcia D, Sears J, Urasawa S, Kapikian, AZ (1988): Relative frequency of rotavirus serotypes 1, 2, 3, and 4 in Venezuelan infants with gastroenteritis. Journal of Clinical Microbiology 26:2092-2095.
16. Gentsch JR, Glass RI, Woods P, Gouvea V, Gorziglia M, Flores J, Das, BK, Bhan MK (1992): Identification of group A rotavirus gene 4 types by polymerase chain reaction. Journal of Clinical Microbiology 30:1365-1373.
17. Georges-Courbot MC, Monges J, Siopathis MR, Roungou JB, Gresenguet G, Bellec L, Bouquety JC, Lanckriet C, Cadoz M, Hessel L, Gouvea V, Clark F, Georges AJ (1991): Evaluation of the efficacy of a low-passage bovine rotavirus (strain WC3) vaccine in children in central Africa. Research in Virology 142:405-411.
18. Gerna G, Passarani N, Sarasini A, Battaglia M (1985): Characterization of serotypes of human rotavirus strains by solid-phase immune electron microscopy. Journal of Infectious Diseases 152: 1143-1151.
19. Glass RI, Gentsch JR, Smith JC (1994): Rotavirus vaccines: Success by reassortment? Science 265:1389-1391.
20. Gombold JL, Ramig RF (1994): Genetics of the rotaviruses. Current Topics in Microbiology and Immunology 185:129-177.
21. Gorziglia M, Larralde G, Kapikian AZ, Chanock RM (1990): Antigenic relationships among human rotaviruses as determined by outer casid VP4. Proceedings of the National Academy of Sciences USA 87:7155-7159.
22. Green KY, Taniguchi K, Mackow ER, Kapikian AZ (1990): Homotypic and heterotypic epitope-specific antibody responses in adult and infant rotavirus vaccinees: Implications for vaccine development. Journal of Infectious Diseases 161:667-679.
23. Greenberg HB, Valdesuso J, van Wyke K, Midthun K, Walsh M, McAuliffe V, Wyatt RG, Kalica AR, Flores J, Hoshino Y (1983): Production and preliminary characterization of monoclonal antibodies directed at two surface proteins of rhesus rotavirus. Journal of Virology 47:267-275.
24. Gunasena S, Nakagomi O, Isegawa Y, Kaga E, Nakagomi T, Steele AD, Flores J, Ueda S (1993): Relative frequency of VP4 gene alleles among human rotaviruses recovered over a 10-year period (1982-1991) from Japanese children with diarrhea. Journal Clinical Microbiology 31:2195-2197.
25. Hoshino Y, Kapikian AZ (1996a): Classification of rotavirus VP4 and VP7 serotypes. Archives of Virology (in press).
26. Hoshino Y, Kapikian AZ (1996b): Unpublished data.
27. Hoshino Y, Saif LJ, Kang SY, Sereno MM, Chen WK, Kapikian AZ (1995): Identification of group A rotavirus genes associated with virulence of a porcine rotavirus and host range restriction of a human rotavirus in the gnotobiotic piglet model. Virology 209: 274-280.
28. Hoshino Y, Kapikian AZ, Chanock RM (1994a): Selection of cold-adapted mutants of human rotaviruses that exhibit various degrees of growth restriction in vitro. Journal of Virology 68:7598-7602.
29. Hoshino Y, Kapikian AZ (1994b): Rotavirus vaccine development for the prevention of severe diarrhea in infants and young children. Trends in Microbiology 2:242-249.
30. Hoshino Y, Kapikian AZ (1994c): Rotavirus antigens. Current Topics in Microbiology and Immunology 185:179-227.
31. Hoshino Y, Saif LJ, Sereno MM, Chanock RM, Kapikian AZ (1988): Infection immunity of piglets to either VP3 or VP7 outer capsid protein confers resistance to challenge with a virulent rotavirus bearing the corresponding antigen. Journal of Virology 62:744-748.
32. Hoshino Y, Sereno MM, Midthun K, Flores J, Kapikian AZ, Chanock RM (1985): Independent segregation of two antigenic specificities (VP3 and VP7) involved in neutralization of rotavirus infectivity. Proceedings of the National Academy of Sciences USA 82:8701-8704.
33. Kapikian AZ, Chanock RM (1996): Rotaviruses. In Fields BN, Knipe DM, Howley PM (eds): "Virology." Philadelphia:Lippincott-Raven, 3rd ed., pp 1657-1708.
34. Kapikian AZ (1994): Rhesus rotavirus-based human rotavirus vaccines and observations on selected non-Jennerian approaches to rotavirus vaccination. In Kapikian AZ (ed): "Viral Infections of the Gastrointestinal Tract." New York: Marcel Dekker, pp 443-470.
35. Kapikian AZ, Vesikari T, Ruuska T, Madore HP, Christy C, Dolin R, Flores J, Green KY, Davidson BL, Gorziglia M, Hoshino Y, Chanock RM, Midthun K, Perez-Schael I (1992): An update on the "Jennerian" and modified "Jennerian" approach to vaccination of infants and young children against rotavirus diarrhea. Advances in Experimental Medicine and Biology 327:59-69.
36. Kapikian AZ, Midthun K, Hoshino Y, Flores J, Wyatt RG, Glass RI, Askaa J, Nakagomi O, Nakagomi T, Chanock RM, Levine MM, Clements ML, Dolin R, Wright PF, Belshe RB, Anderson EL, Potash L (1985): Rhesus rotavirus: A candidate vaccine for prevention of human rotavirus disease. In Lerner RA, Brown F, Chanock RM (eds): "Vaccines 85. Molecular and Chemical Basis of Resistance to Parasitic, Bacterial, and Viral Diseases." New York: Cold Spring Harbor Laboratory, pp 357-367.
37. Larralde G, Flores J (1990): Identification of gene 4 alleles among human rotaviruses by polymerase chain reaction-derived probes. Virology 179:469-473.
38. Mackow ER, Vo PT, Broome R, Bass D, Greenberg HB (1990): Immunization with baculovirus-expressed VP4 protein passively protects against simian and murine rotavirus challenge. Journal of Virology 64:1698-1703.
39. Matsui SM, Offit PA, Vo PT, Mackow ER, Benfield DA, Shaw RD, Padilla-Noriega L, Greenberg HB (1989): Passive protection against rotavirus-induced diarrhea by monoclonal antibodies to the heterotypic neutralization domain of VP7 and the VP8 fragment of VP4. Journal of Clinical Microbiology 27:780-782.
40. Matsuno S, Hasegawa A, Mukoyama A, Inouye S (1985): A candidate for a new serotype of human rotavirus. Journal of Virology 54: 623-624.
41. Mattion NM, Cohen J, Estes MK (1994): The rotavirus proteins. In Kapikian, AZ (ed): "Viral Infections of the Gastrointestinal Tract." New York: Marcel Dekker, pp 169-249.
42. Midthun K, Hoshino Y, Kapikian AZ, Chanock RM (1986): Single gene substitution rotavirus reassortants containing the major neutralization protein (VP7) of human rotavirus serotype 4. Journal of Clinical Microbiology 24:822-826.
43. Midthun K, Greenberg HB, Hoshino Y, Kapikian AZ, Wyatt RG, Chanock RM (1985): Reassortant rotaviruses as potential rotavirus vaccine candidates. Journal of Virology 53:949-954.
44. Mphahlele MJ, Steele AD (1995): Relative frequency of human rotavirus VP4(P) genotypes recovered over a ten-year period from South African children with diarrhea. Journal of Medical Virology 47:1-5.
45. Nakagomi O, Nakagomi T, Akatani K, Ikegami N, Katsushima N (1990): Relative frequency of rotavirus serotypes in Yamagata, Japan over four consecutive rotavirus seasons. Research in Virology 141:459-463.
46. Offit PA (1994): Rotaviruses: Immunological determinants of protection against infection and disease. Advances in Virus Research 44:161-202.
47. Offit PA, Hoffenberg EJ, Santos N, Gouvea V (1993): Rotavirus-specific humoral and cellular immune response after primary symptomatic infection. Journal of Infectious Diseases 167:1436-1440.
48. Offit PA, Shaw RD, Greenberg HB (1986a): Passive protection against rotavirus-induced diarrhea by monoclonal antibodies to surface proteins VP3 and VP7. Journal of Virology 58:700-703.
49. Offit PA, Blavat G (1986b): Identification of two rotavirus genes determining neutralization specificities. Journal of Virology 57:376-378.
50. Padilla-Noriega LP, Arias CF, Lopez S, Snodgrass DR, Taniguchi K, Greenberg HB (1990): Diversity of rotavirus serotypes in Mexican infants with gastroenteritis. Journal of Clinical Microbiology 28: 1114-1119.
51. Programme for Control of Diarrhoeal Diseases (1994): Ninth Programme Report 1992-1993. pp 65-67. World Health Organization, Geneva, Switzerland.
52. Rennels MB, Glass RI, Dennehy PH, Bernstein DI, Pichichero ME, Zito ET, Mack ME, Davidson BL, Kapikian AZ (1996): Safety and efficacy of high-dose rhesus-human reassortant rotavirus vaccines - report of the national multicenter trials. Pediatrics 97:7-13.
53. Rojas AM, Boher Y, Guntinas MJ, Perez-Schael I (1995): Homotypic immune response to primary infection with rotavirus serotype G1. Journal of Medical Virology 47:404-409.
54. Santos N, Riepenhoff-Talty M, Clark HF, Offit P, Gouvea V (1994): VP4 Genotyping of human rotavirus in the United States. Journal of Clinical Microbiology 32:205-208.
55. Shaw RD, Stoner-Ma DL, Estes MK, Greenberg HB (1985): Specific enzyme-linked immunoassay for rotavirus serotypes 1 and 3. Journal of Clinical Microbiology 22:286-291.
56. Silverstein I, Shulman LM, Mendelson E, Shif I (1995): Distribution of both rotavirus VP4 genotypes and VP7 serotypes among hospitalized and nonhospitalized Israeli children. Journal of Clinical Microbiology 33:1421-1422.
57. Steele AD, van Nickerk MC, Mphahlele MJ (1995): Geographic distribution of human rotavirus VP4 genotypes and VP7 serotypes in five South African regions. Journal of Clinical Microbiology 33: 1516-1519.
58. Steele AD, Garcia D, Sears J, Gerna G, Nakagomi O, Flores J (1993): Distribution of VP4 gene alleles in human rotaviruses by using probes to the hyperdivergent region of the VP4 gene. Journal of Clinical Microbiology 31:1735-1740.
59. Stuker G, Oshiro LS, Schmidt NJ (1980): Antigenic comparisons of two new rotaviruses from rhesus monkeys. Journal of Clinical Microbiology 11:202-203.
60. Taniguchi K, Urasawa T, Morita Y, Greenbeg HB, Urasawa S (1987): Direct serotyping of human rotavirus in stools by an enzyme-linked immunosorbent assay using serotype 1-,2-,3-, or 4-specific monoclonal antibodies to VP7. Journal of Infectious Diseases 155: 1159-1166.
61. Timenetsky MCST, Santos N, Gouvea V (1994): Survey of rotavirus and G and P types associated with human gastroenteritis in Sao Paulo, Brazil from 1986 to 1992. Journal of Clinical Microbiology 32:2622-2624.
62. Unicomb LE, Coulson BS, Bishop RF (1989): Experience with an enzyme immunoassay for serotyping human group A rotaviruses. Journal of Clinical Microbiology 27:586-588.
63. Urasawa S, Urasawa T, Wakasugi F, Kobayashi N, Taniguchi K, Lintag IC, Saniel MC, Goto H (1990): Presumptive seventh serotype of human rotavirus. Archives of Virology 113:279-282.
64. Urasawa S, Urasawa T, Taniguchi K, Wakasugi F, Kobayashi N, Chiba S, Sakurada N, Morita M, Morita O, Tokieda M, Kawamoto H, Minekawa Y, Ohseto M (1989): Survey of human rotavirus serotypes in different locales in Japan by enzyme-linked immunosorbent assay with monoclonal antibodies. Journal of Infectious Diseases 160:44-51.
65. Urasawa S, Urasawa T, Taniguchi K (1982): Three human rotavirus serotypes demonstrated by plaque neutralization of isolated strains. Infection and Immunity 38:781-784.
66. Ushijima H, Mukoyama A, Hasegawa A, Nishimura S, Konishi K, Bosu K (1994): Serotyping of human rotavirus in the Tokyo area (1990-1993) by enzyme immunoassay with monoclonal antibodies and by reverse transcription and polymerase chain reaction amplification. Journal of Medical Virology 44:162-165.
67. Vesikari T (1994): Bovine rotavirus-based rotavirus vaccines in humans. In Kapikian AZ (ed): "Viral Infections of the Gastrointestinal Tract." New York: Marcel Dekker, pp 419-442.
68. Vesikari T (1993): Clinical trials of live oral rotavirus vaccine: The Finnish experience. Vaccine 11:255-261.
69. Vesikari T, Isolauri E, Delem A, D'Hondt E, Andre FE, Zissis G (1983): Immunogenicity and safety of live oral attenuated bovine rotavirus vaccine strain 4237 in adults and young children. Lancet ii:807-811.
70. Woode GN, Jones J, Bridger J (1975): Levels of colostral antibodies against neonatal calf diarrhoea virus. Veterinary Record 97:148-149.
71. Wyatt RG, Kapikian AZ, Hoshino Y, Flores J, Midthun K, Greenbeg HB, Glass RI, Askaa J, Levine MM, Black RE, Clements ML, Potash L, London WT (1985): Development of rotavirus vaccines. In "Control and Eradication of Infectious Diseases. An International Symposium." PAHO Copublication Series No. 1. Pan American Health Organization, Washington, D.C. pp 17-28.
72. Wyatt RG, James Jr HD, Pittman AL, Hoshino Y, Greenberg HB, Kalica AR, Flores J, Kapikian AZ (1983): Direct isolation in cell culture of human rotaviruses and their characterization into four serotypes. Journal of Clinical Microbiology 18:310-317.
73. Wyatt RG, Greenberg HB, James Jr HD, Pittman AL, Kalica AR, Flores J, Chanock RM, Kapikian AZ (1982): Definition of human rotavirus serotypes by plaque reduction assay. Infection and Immunity 37:110-115.